Mukka Proteins Peer Comparison
NSE: MUKKA | BSE: 544135
₹27.81
₹0.20
(0.72%)
As on 09-Nov-2026IST
Market cap
₹831 Cr
Revenue (TTM)
₹2,033 Cr
P/E Ratio
10.5
P/B Ratio
1.5
Div. Yield
0 %
Edit
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
831 | 39,025 | 14,806 | 13,986 | 7,920 |
Revenue (₹ Cr) |
2,033 | 2,371 | 4,131 | 3,392 | 979 |
Net Profit (₹ Cr) |
84.15 | 376.21 | 411.10 | 565.65 | 279.70 |
Net Margin (%) |
4.08 | 15.66 | 9.78 | 16.21 | 27.97 |
RoE (%) |
15.28 | 14.78 | 13.13 | 17.62 | 76.43 |
Price to Earnings |
10.49 | 103.73 | 36.01 | 24.98 | 28.32 |
Price-To-Book |
1.55 | 14.52 | 4.41 | 4.20 | 18.66 |
Income Statement (₹ Cr)
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,449.45 | 2,192.49 | 3,510.50 | 2,950.94 | 878.40 |
|
Total Income
|
1,478.13 | 2,266.90 | 3,582.50 | 3,033.47 | 896.80 |
|
Total Expenditure
|
1,334.87 | 1,584.97 | 2,891.50 | 2,350.16 | 569.40 |
|
EBITDA
|
114.58 | 607.53 | 619.00 | 600.78 | 309.00 |
|
Depreciation
|
16.59 | 166.86 | 126.40 | 98.63 | 11.70 |
|
EBIT
|
97.99 | 440.67 | 492.60 | 502.15 | 297.30 |
|
Interest
|
53.60 | 40.88 | 19.30 | 24.13 | 2.00 |
|
Other Income
|
28.68 | 74.40 | 72.00 | 82.53 | 18.40 |
|
Exceptional Items
|
-- | -8.00 | -20.30 | -- | 6.60 |
|
Profit before Tax
|
75.14 | 466.19 | 525.00 | 560.56 | 320.30 |
|
Provision for Tax
|
18.06 | 117.28 | 123.90 | 140.49 | 80.20 |
|
Profit after Tax
|
57.09 | 348.91 | 401.10 | 420.06 | 240.10 |
Liabilities (₹ Cr)
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
499.09 | 2,483.69 | 3,138.70 | 3,023.16 | 384.00 |
|
Minority Interest
|
29.69 | -- | -- | 29.52 | -- |
|
Non-Current Liabilities
|
43.05 | 321.65 | 318.60 | 268.17 | 229.90 |
|
Current Liabilities
|
1,048.93 | 904.59 | 1,086.20 | 527.09 | 128.40 |
|
Total Liabilities
|
1,621.13 | 3,709.93 | 4,620.30 | 3,855.82 | 750.80 |
Assets (₹ Cr)
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
331.92 | 2,228.49 | 1,925.10 | 1,125.20 | 248.00 |
|
Current Assets
|
1,288.83 | 1,481.44 | 2,618.40 | 2,722.74 | 494.30 |
|
Total Assets
|
1,621.13 | 3,709.93 | 4,620.30 | 3,855.82 | 750.80 |
|
Total Debt*
|
767.77 | 95.13 | 0.00 | 29.59 | 0.00 |
|
Net Current Assets
|
239.90 | 576.85 | 1,532.20 | 2,195.65 | 365.90 |
|
Contingent Liabilities
|
61.31 | 97.31 | -- | -- | 1.50 |
Cashflow (₹ Cr)
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-111.27 | 509.13 | 650.80 | 458.13 | 174.80 |
|
Cash Flow from Investing Activities
|
-145.98 | -395.41 | -512.40 | -248.27 | 7.60 |
|
Cash from Financing Activities
|
267.05 | -123.68 | -82.60 | -70.93 | -134.50 |
|
Net Cash Inflow / Outflow
|
9.81 | -9.96 | 55.80 | 138.93 | 47.90 |
Ratios
Profitability Ratios
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
ROCE (%)
|
11.93 | 20.97 | 18.92 | 21.10 | 98.11 |
|
ROE (%)
|
12.15 | 15.16 | 14.14 | 15.31 | 73.20 |
|
ROA (%)
|
4.23 | 10.09 | 10.31 | 11.85 | 37.26 |
|
EBIT Margin (%)
|
9.88 | 31.10 | 19.68 | 23.16 | 37.27 |
|
Net Margin (%)
|
3.86 | 15.39 | 11.20 | 13.85 | 26.77 |
|
Cash Profit Margin (%)
|
4.98 | 23.50 | 15.03 | 17.07 | 27.35 |
Growth Ratios
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
44.02 | 29.38 | 23.64 | 12.51 | 21.24 |
|
EBIT Growth (%)
|
30.24 | 53.37 | 7.72 | 14.07 | 15.44 |
|
Net Profit Growth (%)
|
18.69 | 105.08 | -1.38 | 9.79 | 32.65 |
|
EPS Growth (%)
|
12.06 | 101.82 | -1.79 | 9.81 | 32.65 |
|
Book Value Growth (%)
|
13.25 | 16.76 | 19.89 | 22.41 | 41.18 |
Valuation Ratios
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Price / Earnings
|
10.60 | 58.91 | 26.06 | 17.04 | 43.36 |
|
Price / Book Value
|
1.11 | 8.29 | 3.38 | 2.36 | 27.11 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.52 | 0.57 | 1.66 |
|
EV/EBITDA
|
8.79 | 30.12 | 14.57 | 9.02 | 30.65 |
|
Market Cap (₹ Cr)
|
551.66 | 20,554.39 | 10,450.76 | 7,121.50 | 10,410.62 |
Solvency Ratios
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.54 | 0.04 | 0.00 | 0.01 | 0.00 |
|
Short term debt to equity ratio
|
1.44 | 0.03 | -- | 0.01 | -- |
|
Current Ratio
|
1.23 | 1.64 | 2.41 | 5.17 | 3.85 |
|
Quick Ratio
|
0.41 | 1.47 | 2.41 | 3.32 | 3.37 |
|
Interest Coverage
|
2.40 | 12.40 | 28.20 | 24.24 | 161.15 |
Operating Efficiency Ratios
| Mukka Proteins | Sai Life Sciences | Indegene | Marksans Pharma | Sanofi Consumer Healthcare India | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.55 | 17.04 | 27.97 | 21.84 | 3.37 |
|
Asset Turnover
|
1.10 | 0.63 | 0.90 | 0.86 | 1.43 |
|
Receivable days
|
47.06 | 60.56 | 90.10 | 71.16 | 8.58 |
|
Inventory Days
|
175.18 | 22.43 | 0.00 | 109.20 | 20.38 |
|
Payable days
|
59.68 | 194.31 | -- | 91.82 | 118.89 |
|
Cash Conversion Cycle
|
162.56 | -111.32 | -- | 88.55 | -89.93 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
